[Abstract]2022 Apr;42(4):694-705
Benefits for People With Type 2 Diabetes People with type 2 diabetes saw two noticeable improvements: Lower blood sugar levels , including meaningful HbA1c reductions Steady weight loss , though typically a little less than non-diabetic participants a pattern also seen with injected GLP-1 receptor agonists The blood sugar improvements reflect how GLP-1 receptor agonists support insulin activity and slow digestion, which may help stabilise glucose throughout the day
Research Findings The research foundation for Epithalon is substantial, though much of this work has been conducted in Russia and published primarily in Russian or Eastern European journals, with less representation in mainstream Western scientific literature
To allow cell movement, TB-500, an actin-binding protein, helps sequester actin where it is most beneficial
Over-the-counter remedies may offer temporary relief
Environ Mol Mutagen 50(3):201212